1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Carlo Carnaghi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 71 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells

Vitali, E., Boemi, I., Piccini, S., Tarantola, G., Smiroldo, V., Lavezzi, E., Brambilla, T., Zerbi, A., Carnaghi, C., Mantovani, G., Spada, A. & Lania, A. G., Jun 1 2020, In : Molecular and Cellular Endocrinology. 509, 110803.

Research output: Contribution to journalArticle

  • The impact of cancer: An Italian descriptive study involving 500 long-term cancer survivors

    Muzzatti, B., Gipponi, K., Flaiban, C., Cormio, C., Carnaghi, C., Tralongo, P., Caruso, M., Cavina, R., Tirelli, U. & Annunziata, M. A., May 2019, In : European Journal of Cancer Care. 28, 3, e13007.

    Research output: Contribution to journalArticle

  • The impact of cancer: An Italian descriptive study involving 500 long-term cancer survivors

    Muzzatti, B., Gipponi, K., Flaiban, C., Cormio, C., Carnaghi, C., Tralongo, P., Caruso, M., Cavina, R., Tirelli, U. & Annunziata, M. A., May 2019, In : European Journal of Cancer Care. 28, 3, 7 p., e13007.

    Research output: Contribution to journalArticle

  • Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary

    Singh, S., Carnaghi, C., Buzzoni, R., Pommier, R. F., Raderer, M., Tomasek, J., Lahner, H., Valle, J. W., Voi, M., Bubuteishvili-Pacaud, L., Lincy, J., Wolin, E., Okita, N., Libutti, S. K., Oh, D-Y., Kulke, M., Strosberg, J., Yao, J. C., Pavel, M. E., Fazio, N. & 1 others, RAD001 in Advanced Neuroendocrine Tumors, F. T. RADIANT. S. G., 2018, In : Neuroendocrinology. 106, 3, p. 211-220 10 p.

    Research output: Contribution to journalArticle

  • Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary

    RAD001 in Advanced Neuroendocrine Tumors, Fourth Trial (RADIANT-4) Study Group, 2018, In : Neuroendocrinology. 106, 3, p. 211-220 10 p.

    Research output: Contribution to journalArticle